Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| HilleVax, Inc. | 6,724,000 | 6,724,000 | 0 | 9,750 | 13,381 | 68.43% | +3,631 |
| Ovid Therapeutics, Inc. | 7,531,996 | 7,531,996 | 0 | 2,350 | 2,485 | 12.71% | +136 |
| American Well Corporation | 77,733 | 77,733 | 0 | 613 | 691 | 3.53% | +79 |
| Third Harmonic Bio, Inc. | 36,835 | 36,835 | 0 | 128 | 200 | 1.02% | +72 |
| Standard Biotools, Inc. | 16,515 | 16,515 | 0 | 18 | 20 | 0.10% | +2 |
| Turnstone Biologics | 895,824 | 895,824 | 0 | 367 | 322 | 1.64% | -46 |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 1,475,121 | 1,475,121 | 0 | 1,068 | 1,003 | 5.13% | -65 |
| Lyell Immunopharma, Inc. | 823,317 | 41,165 | -782,152 | 443 | 364 | 1.86% | -79 |
| Shattuck Labs, Inc. | 515,619 | 515,619 | 0 | 490 | 408 | 2.09% | -82 |
| Equillium, Inc. | 1,824,977 | 1,824,977 | 0 | 712 | 575 | 2.94% | -137 |
| Rani Therapeutics Holdings, Inc. | 203,190 | 203,190 | 0 | 256 | 104 | 0.53% | -152 |